il-2 pre-treated cd19 cells
Cell therapyexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Dec 1, 2016 (NCT02992834)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- B-lymphocyte antigen CD19Immunity, passive
CD19 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- il-2 pre-treated cd19 cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02992834 | Phase 4 | Dec 1, 2016 | The First People's Hospital of Changzhou |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| The First People's Hospital of Changzhou | Academic/Hospital | 1 | 1 | 1 | 2016 |
1 organizations
Page 1 / 1